Recombinant human insulin genetically engineered bacterium high expression strain selection culture medium and preparation method
A technology of recombinant human insulin and genetically engineered bacteria, which is applied in the direction of insulin, microbial-based methods, biochemical equipment and methods, etc., can solve the problems of single nutrient composition in the culture medium, increased pollution probability, complicated screening process, etc., to reduce pollution , screening stability, and improved screening method performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] according to figure 1 Precisely prepare 1 liter of recombinant human insulin genetically engineered bacteria high-expression strain screening medium, each component and its quality are: peptone 1.5g, yeast powder 3g, potassium dihydrogen phosphate 1.5g, disodium hydrogen phosphate 4.5g , sodium chloride 0.3g, ammonium chloride 0.1g, adjust the pH to 6.80-7.20, and the balance is purified water.
[0034] Weigh the raw materials of each component according to the stated ratio, dissolve them in purified water to 90% of the final volume, adjust the pH to 6.80-7.20, after constant volume, sterilize at 121.0°C for 30 minutes, add sterile kanamycin to a final concentration of 40mg / L.
[0035] Prepare the screening medium for the high-expression strain of recombinant human insulin genetically engineered bacteria, using existing recombinant human insulin genetically engineered bacteria (host bacteria is E.colik12W3110, expression plasmid is PL-82, containing kanamycin (Kana) a...
Embodiment 2
[0037] according to figure 1 According to the process, 1 liter of recombinant human insulin genetically engineered bacteria high-expression strain screening medium was precisely prepared. The components and their quality were: 3g of peptone, 6g of yeast powder, 3.5g of potassium dihydrogen phosphate, 6.5g of disodium hydrogen phosphate, Sodium chloride 0.6g, ammonium chloride 0.3g, adjust the pH to 6.80-7.20, and the balance is purified water.
[0038] Weigh the raw materials of each component according to the stated ratio, dissolve them in purified water to 90% of the final volume, adjust the pH to 6.80-7.20, after constant volume, sterilize at 121.0°C for 30 minutes, add sterile kanamycin to a final concentration of 30mg / L.
[0039] Prepare the screening medium for the high-expression strain of recombinant human insulin genetically engineered bacteria, using the existing recombinant human insulin genetically engineered bacteria (host bacteria is E.colik12W3110, expression ...
Embodiment 3
[0041] according to figure 1 According to the process, 1 liter of recombinant human insulin genetically engineered bacteria high-expression strain screening medium was precisely prepared. The components and their mass fractions were: peptone 2g, yeast powder 5g, potassium dihydrogen phosphate 2.5g, disodium hydrogen phosphate 5g, chlorine 0.5 g of sodium chloride and 0.2 g of ammonium chloride were used to adjust the pH to 7, and the balance was purified water.
[0042] Weigh the raw materials of each component according to the stated ratio, dissolve them in purified water to 90% of the final volume, adjust the pH to 6.80-7.20, after constant volume, sterilize at 121.0°C for 30 minutes, add sterile kanamycin to a final concentration of 40mg / L.
[0043] Prepare the screening medium for the high-expression strain of recombinant human insulin genetically engineered bacteria, using the existing recombinant human insulin genetically engineered bacteria (host bacteria is E.colik12...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap